Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05357469 · ClinicalTrials.gov registry record · NA
Innovative Treatment of Chemotherapy-Induced Painful Peripheral Neuropathy in Adolescents and Young Adults With Cancer: A Two Arm Pilot Study
A NA study of Peripheral Neuropathy, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 38
- Enrollment target
- 1
- Study location
NCT05357469 is a NA study of Peripheral Neuropathy that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 38 participants, below the 79-participant average among 27 other Peripheral Neuropathy trials with a reported enrollment target (52% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05357469, a NA study of Peripheral Neuropathy, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
- 1
- Study location
Study Summary
To evaluate the efficacy and safety of Scrambler therapy (ST) for chemotherapy-induced painful peripheral neuropathy (CIPN), and the impact of ST on physical functioning and quality of life (QoL) in adolescents and young adults (AYA) cancer patients. In this proposed study, we will conduct a two-arm prospective, randomized wait-list controlled clinical trial to investigate the effectiveness of ST on pain and CIPN in AYAs with cancer.
Conditions Studied
Interventions
- DEVICE Immediate St (Scrambler Therapy)
- DEVICE Waitlist ST (Scrambler Therapy)
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2022-07-14 |
| Est. Completion | 2026-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05357469
The ClinicalTrials.gov registry entry for NCT05357469 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 79-participant average among 27 other Peripheral Neuropathy trials with a reported enrollment target (52% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Peripheral Neuropathy appearing as the primary indexed condition, and to 2 interventions - of which Immediate St (Scrambler Therapy) is the first listed.
NCT05357469 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT05357469 about?
NCT05357469 is a clinical study titled "Innovative Treatment of Chemotherapy-Induced Painful Peripheral Neuropathy in Adolescents and Young Adults With Cancer: A Two Arm Pilot Study". To evaluate the efficacy and safety of Scrambler therapy (ST) for chemotherapy-induced painful peripheral neuropathy (CIPN), and the impact of ST on physical functioning and quality of life (QoL) in adolescents and young adults (AYA) cancer patients. In this proposed study, we will conduct a two-ar...
What is the current status of trial NCT05357469?
This trial is currently recruiting. It is a NA study. The enrollment target is 38 participants. The study started on 2022-07-14. Estimated completion is 2026-07-31.
What conditions does trial NCT05357469 study?
This clinical trial studies the following conditions: Peripheral Neuropathy.
What interventions are being tested in trial NCT05357469?
The interventions under investigation include: Immediate St (Scrambler Therapy) (DEVICE), Waitlist ST (Scrambler Therapy) (DEVICE).
Who is sponsoring clinical trial NCT05357469?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05357469 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Peripheral Neuropathy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Replexa+ Shortwave Diathermy Device for Patients Diagnosed With Peripheral Artery Disease and Peripheral Neuropathy
RECRUITING · NA
-
DoD AtMS for Posttraumatic Peripheral Neuropathic Pain
RECRUITING · NA
-
Intermittent Dosing of Dorsal Root Ganglion Stimulation as an Alternate Paradigm to Continuous Low-Frequency Therapy
RECRUITING · NA
-
Reliability of Force Measurement Within the Carbon Fiber Orthosis Proximal Cuff
RECRUITING · NA
-
Massage Therapy in Reducing Chemotherapy-Induced Peripheral Neuropathy in Patients With Gastrointestinal or Breast Malignancies
ACTIVE NOT RECRUITING · NA
-
Clinical Study of a Micro-Implantable Pulse Generator for the Treatment of Peripheral Neuropathic Pain (COMFORT 2)
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.